Clinical trial

Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging

NCT01277263

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2010-12-01

PhaseN/A

Study timeline

Study start (unknown)2010-12-01Date precision: month

Registry last updated2022-11-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Diffuse Optical Spectroscopy ImagingDEVICE

Sponsors & collaborators

University of California, Irvinelead sponsor

Beckman Laser Institute University of California Irvinecollaborator

Mapped research locations

OrangeCalifornia, United States1 IrvineCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01277263 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.